Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  SHL Telemedicine Ltd.    SHLTN   IL0010855885

SHL TELEMEDICINE LTD.

(SHLTN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

SHL Telemedicine expands to The Netherlands and signs an agreement to acquire Kadima BV / 24CARE Inkoop BV

share with twitter share with LinkedIn share with facebook
08/28/2019 | 02:05am EDT

SHL Telemedicine expands to The Netherlands and signs an agreement to acquire Kadima BV / 24CARE Inkoop BV

Tel Aviv / Zurich, August 28, 2019 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announced today that that it has signed an agreement to acquire 51% of Netherlands based Kadima BV, 100% owner of 24CARE Inkoop BV, with an option to acquire the remaining 49% within 24 months of closing. The closing of the transaction is expected to take place by end of 2019 subject to signing of a definitive agreement.

24CARE Inkoop BV is a leading provider of arrhythmia monitoring services in the Dutch market, performing over twenty thousand annual ECG diagnosis for patients with heart rhythm disorders on behalf of a wide network of general practitioners. The service is reimbursed by all major health insurance companies. 24CARE has also been expanding into chronic care, working with leading Dutch hospitals on Congestive Heart Failure (CHF) patient management to reduce cost of care and improve outcomes. 24CARE has 22 employees and is expected to generate annual revenues of € 3 to € 4 M in 2019 and will be accretive to SHL.

Yoav Rubinstein, CEO of SHL, said: "With this acquisition, we expand our geographic footprint in Europe and reinforce SHL as the clear European telemedicine leader. The Kadima acquisition will further expand our chronic care business, which has been highly successful in Germany, and support the development of Kadima in the Dutch market."




Provider
Channel
Contact
EQS Group Ltd., Switzerland
switzerland.eqs.com


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
cs.switzerland@eqs.com
+41 41 763 00 50

share with twitter share with LinkedIn share with facebook
All news about SHL TELEMEDICINE LTD.
10/14Mayo Clinic Collaborates with SHL Telemedicine using SmartHeart™ Techno..
TE
10/08SHL TELEMEDICINE : announces Annual General Meeting Results
PU
10/08SHL announces Annual General Meeting Results
TE
09/25SHL TELEMEDICINE : announces half-year results 2020 – Telemedicine is at a..
PU
09/25SHL announces half-year results 2020 – Telemedicine is at a tipping poi..
TE
09/25SHL TELEMEDICINE : Half Year Report 2020
PU
09/21SHL TELEMEDICINE : announces Special announces Special General Meeting Results
PU
09/21SHL announces Special General Meeting Results
TE
09/16SHL TELEMEDICINE : announces invitation to the Annual General Meeting
PU
09/03SHL announces invitation to the Annual General Meeting
TE
More news
Financials (USD)
Sales 2019 41,9 M - -
Net income 2019 5,70 M - -
Net Debt 2019 6,20 M - -
P/E ratio 2019 10,4x
Yield 2019 -
Capitalization 72,0 M 71,8 M -
EV / Sales 2018 1,17x
EV / Sales 2019 1,56x
Nbr of Employees 551
Free-Float 10,2%
Chart SHL TELEMEDICINE LTD.
Duration : Period :
SHL Telemedicine Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHL TELEMEDICINE LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Managers
NameTitle
Erez Nachtomy Chief Executive Officer & Director
Yariv Alroy Chairman
Yossi Vadnagra Chief Financial Officer
Yoni Dagan Chief Technology Officer
Amir Lerman Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SHL TELEMEDICINE LTD.13.76%72
CVS HEALTH CORPORATION-18.90%78 849
HCA HEALTHCARE, INC.-7.59%46 172
AIER EYE HOSPITAL GROUP CO., LTD.87.93%35 250
FRESENIUS MEDICAL CARE AG & CO. KGAA4.06%23 792
FRESENIUS SE & CO. KGAA-31.51%22 680